Inhibitors of Crystallin Aggregation

dc.contributor.advisorMartic, Sanela
dc.contributor.authorShoemaker, Gina
dc.date.accessioned2018-01-25T15:18:37Z
dc.date.available2018-01-25T15:18:37Z
dc.description.abstractCataract is one of the leadings causes of vision loss worldwide. The exact mechanism is unknown, but aggregation of crystallin proteins, which make up much of the protein content of the lens and are involved in maintaining the integrity of the lens, leads to the characteristic clouding of the lens. Given this, it is of great clinical importance to identify possible inhibitors of crystallin aggregation. Phthalocyanine compounds are known to inhibit aggregation of proteins such as tau and α-synuclein, which are related to neurodegeneration. Their effectiveness as inhibitors of crystallin aggregation has not been evaluated. To characterize the potential of phthalocyanines as inhibitors of crystallin aggregation, fluorescence proteostat aggregation assays and transmission electron microscopy (TEM) were used to detect the presence of aggregation via β-sheet character and determine specific aggregation morphology respectively. It was determined that porphyrazine 285 (PZ285) exhibited poor inhibition of crystallin aggregation due to its minimal solubility in aqueous solution. Phthalocyanine tetrasulfonate (PcTS) showed some reduction in crystallin aggregation in a concentration-dependent manner.en_US
dc.identifier.urihttp://hdl.handle.net/10323/4619
dc.subjectCrystallinen_US
dc.subjectCataractsen_US
dc.subjectProtein aggregationen_US
dc.subjectTransmission electron microscopyen_US
dc.subjectPhthalocyanineen_US
dc.subjectFluorescence proteostat aggregation assayen_US
dc.titleInhibitors of Crystallin Aggregationen_US
dc.typeThesiseng

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Gina Shoemaker Honors Thesis.pdf
Size:
2.16 MB
Format:
Adobe Portable Document Format
Description:
Honors college thesis
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
3.41 KB
Format:
Item-specific license agreed upon to submission
Description: